NKore BioTherapeutics Cleared FDA Pre-IND Meeting
The company has received regulatory guidance for its allogeneic natural killer cell cancer therapy candidate.
Live Poll
Do you trust that private biotechnology firms will prioritize patient safety in their cancer therapy development?